Pharmaceutical Technology
April 02, 2002
Articles
26
4
Powdered self-emulsified dosage forms provide an attractive alternative to filled-capsule preparations, but the selection of a proper excipient is crucial.
April 01, 2002
Articles
26
4
In this study, the authors examine the suitability of 0.45 µm–rated filters to be used as sterilizing and bioburden-reduction filters against significant populations of organisms such as B. diminuta in a wide range of differential pressures.
April 01, 2002
Contract Services
26
4
The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.
April 01, 2002
Articles
26
4
By moving uniformity monitoring back to the blender phase, blend variations that result from factors such as particle distribution and environmental temperature and humidity can be identified early.
April 01, 2002
Articles
26
4
This article discusses the use of ion mobility spectrometry as an alternative to high-performance liquid chromatography to reduce the amount of time spent on the cleaning verification process.
April 01, 2002
Columns
26
4
Proposed funding increases for FDA reflect plans to significantly increase user fees collected from manufacturers under the Presciption Drug User Fee Act.
April 01, 2002
Articles
26
4
Eventual change in the dissolution characteristics of some dosage forms, which is ascribed to cross-linking of gelatin, continues to present challenges to drug manufacturers. The authors discuss the causes, mechanisms, and solutions to the problem.
April 01, 2002
Contract Services
26
4
Reverse auctions can benefit both buyers and suppliers of goods and services, but extensive preparation and careful management are required to obtain those benefits.
April 01, 2002
Columns
26
4
In Part I of this two-part series, the authors discuss the need to follow GMPs for lipid-vesicle fabrication that result in size uniformity, delivery of sufficient drug concentration, and stability.